Thromb Haemost 2010; 104(03): 650-652
DOI: 10.1160/TH10-01-0022
Letters to the Editor
Schattauer GmbH

Synergism between factor XII –4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

Authors

  • Diana Hernández-Romero

    1   Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain
  • Francisco Marín

    1   Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain
  • Kaeng W. Lee

    2   University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
  • Vanessa Roldán

    3   Centro Regional de Hemodonación. Universidad de Murcia, Murcia, Spain
  • Juan Caturla

    4   Hospital General Universitario de Alicante, Alicante, Spain
  • Javier Corral

    3   Centro Regional de Hemodonación. Universidad de Murcia, Murcia, Spain
  • Mariano Valdés

    1   Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain
  • Gregory Y. H. Lip

    2   University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
  • Vicente Vicente

    3   Centro Regional de Hemodonación. Universidad de Murcia, Murcia, Spain
  • Rocío González-Conejero

    3   Centro Regional de Hemodonación. Universidad de Murcia, Murcia, Spain

Financial support: Dr. Hernández-Romero holds a postdoctoral position funded by the Instituto de Salud Carlos III. This work was partially supported by RD06/0014/0039 (RECAVA).
Further Information

Publication History

Received: 08 January 2010

Accepted after minor revision: 17 April 2010

Publication Date:
23 November 2017 (online)

Preview